首页 > 市场调查报告书 > 製药

基因治疗学和RNAi 核酸药物

市场调查报告书

商品编码

1390695

2023-2028年按类型、製造商类型、合成技术、给药途径、应用和地区分類的胜肽治疗市场报告

Peptide Therapeutics Market Report by Type, Type of Manufacturer, Synthesis Technology, Routes of Administration, Application, and Region 2023-2028

出版日期: 2023年11月24日 | 出版商:

IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

抽象的

2022年全球胜肽治疗市场规模达392亿美元。展望未来， IMARC Group预计到2028年市场规模将达到661亿美元，2022-2028年复合年增长率（CAGR）为9.10%。

胜肽是有效的选择性讯号分子，可与特定的细胞表面受体（例如离子通道和 G 蛋白偶联受体 (GPCR)）结合并触发细胞内效应。他们在製药业设计新型再生疗法，可以针对多种细胞并操纵它们的反应。与其他治疗方案相比，这些疗法毒性较小、相对安全且耐受性良好。因此，它们在世界各地治疗癌症、损伤、传染病、代谢紊乱和美学问题的临床实践中越来越受欢迎。

胜肽治疗市场趋势：

急性和慢性疾病的日益流行，以及医疗设施的普及，是积极影响胜肽开发创新疗法需求的主要因素之一。此外，胜肽疗法也用于药妆手术，以减缓皮肤老化的过程。再加上人们对外表的意识不断增强以及对保持年轻健康皮肤的渴望，正在推动整容手术和胜肽疗法在世界各地的采用。除此之外，随着减少注射频率、提高稳定性和其他物理特性的新型合成策略的引入，肽疗法被广泛用于糖尿病患者的注射。这与糖尿病发病率的增加以及对快速和精确治疗方法的日益偏好相结合，正在影响肽疗法相对于口服药物的使用。此外，个人化和标靶治疗的新兴趋势正在催化对多功能胜肽基材料的需求。再加上开发用于治疗自体免疫和发炎性疾病的新型胜肽疗法的资金不断增加，预计将创造积极的市场前景。

本报告回答的关键问题

全球肽治疗市场有多大？
2023-2028年全球胜肽治疗市场的预期成长率是多少？
推动全球胜肽治疗市场的关键因素是什么？
COVID-19 对全球胜肽治疗市场有何影响？
全球肽治疗市场按类型划分是怎样的？
根据製造商类型，全球胜肽治疗市场的细分情况如何？
基于合成技术的全球胜肽治疗市场的细分情况如何？
根据给药途径，全球胜肽治疗市场的细分情况如何？
基于应用的全球胜肽治疗市场的细分情况如何？
全球胜肽治疗市场的关键区域有哪些？
谁是全球胜肽治疗市场的主要参与者/公司？

北美洲
- 美国
  - 市场走向
  - 市场预测
- 加拿大
  - 市场走向
  - 市场预测
亚太
- 中国
  - 市场走向
  - 市场预测
- 日本
  - 市场走向
  - 市场预测
- 印度
  - 市场走向
  - 市场预测
- 韩国
  - 市场走向
  - 市场预测
- 澳洲
  - 市场走向
  - 市场预测
- 印尼
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
欧洲
- 德国
  - 市场走向
  - 市场预测
- 法国
  - 市场走向
  - 市场预测
- 英国
  - 市场走向
  - 市场预测
- 义大利
  - 市场走向
  - 市场预测
- 西班牙
  - 市场走向
  - 市场预测
- 俄罗斯
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
拉丁美洲
- 巴西
  - 市场走向
  - 市场预测
- 墨西哥
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
中东和非洲
- 市场走向
- 按国家/地区分類的市场细分
- 市场预测

第 12 章：SWOT 分析

概述
优势
弱点
机会
威胁

第 13 章：价值链分析

第 14 章：波特五力分析

概述
买家的议价能力
供应商的议价能力
竞争程度
新进入者的威胁
替代品的威胁

第 15 章：价格分析

第16章：竞争格局

市场结构
关键参与者
关键参与者简介
- Amgen Inc.
- Apitope International NV
- Arch Biopartners Inc.
- AstraZeneca plc
- Circle Pharma Inc.
- Corden Pharma GmbH
- F. Hoffmann-La Roche AG
- Ipsen Group
- Lonza Group AG
- Novo Nordisk A/S
- Pfizer Inc.
- Teva Pharmaceuticals Industries Ltd.
- Zealand Pharma A/S

简介目录图表

Product Code: SR112023A4510

Abstract

The global peptide therapeutics market size reached US$ 39.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 66.1 Billion by 2028, exhibiting a growth rate (CAGR) of 9.10% during 2022-2028.

Peptides are efficacious and selective signaling molecules that bind to specific cell surface receptors, such as ion channels and G protein-coupled receptors (GPCRs) and trigger intracellular effects. They are employed in the pharmaceutical industry to design novel regenerative therapeutics that can target a wide range of cells and manipulate their responses. These therapeutics are less toxic, relatively safe, and well-tolerated than other treatment options. As a result, they are gaining traction in clinical practices worldwide to manage cancer, injuries, infectious diseases, metabolic disorders, and aesthetic concerns.

Peptide Therapeutics Market Trends:

The growing prevalence of acute and chronic diseases, along with the rising access to medical facilities, represents one of the leading factors positively influencing the demand for peptides to develop innovative therapies. Moreover, peptides therapies are used in cosmeceutical surgeries to slow down the process of skin aging. This, coupled with the increasing consciousness among individuals about physical appearance and the desire to retain young and healthy skin, is driving the adoption of cosmetic surgeries and peptide therapeutics around the world. Apart from this, with the introduction of novel synthetic strategies that reduce injection frequency and improve stability and other physical properties, peptide therapeutics are widely being used in injections for diabetic patients. This, in confluence with the increasing incidence of diabetes and the growing preference for quick and precise treatment methods, is influencing the use of peptide therapeutics over oral medications. Furthermore, the emerging trend of personalized and targeted treatments is catalyzing the demand for multifunctional peptide-based materials. This, along with the rising funding to develop novel peptide therapeutics for treating autoimmune and inflammatory diseases, is projected to create a positive market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global peptide therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, type of manufacturer, synthesis technology, routes of administration and application.

Breakup by Type:

Innovative

Generic

Breakup by Type of Manufacturer:

Outsourced

In-house

Breakup by Synthesis Technology:

Solid Phase Peptide Synthesis

Liquid Phase Peptide Synthesis

Hybrid Technology

Breakup by Routes of Administration:

Parenteral

Oral

Others

Breakup by Application:

Gastrointestinal Disorders

Neurological Disorders

Metabolic Disorders

Cancer

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Apitope International NV, Arch Biopartners Inc., AstraZeneca plc, Circle Pharma Inc., Corden Pharma GmbH, F. Hoffmann-La Roche AG, Ipsen Group, Lonza Group AG, Novo Nordisk A/S, Pfizer Inc., Teva Pharmaceuticals Industries Ltd. and Zealand Pharma A/S.

Key Questions Answered in This Report

1. How big is the global peptide therapeutics market?
2. What is the expected growth rate of the global peptide therapeutics market during 2023-2028?
3. What are the key factors driving the global peptide therapeutics market?
4. What has been the impact of COVID-19 on the global peptide therapeutics market?
5. What is the breakup of the global peptide therapeutics market based on the type?
6. What is the breakup of the global peptide therapeutics market based on the type of manufacturer?
7. What is the breakup of the global peptide therapeutics market based on the synthesis technology?
8. What is the breakup of the global peptide therapeutics market based on the routes of administration?
9. What is the breakup of the global peptide therapeutics market based on the application?
10. What are the key regions in the global peptide therapeutics market?
11. Who are the key players/companies in the global peptide therapeutics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Peptide Therapeutics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Innovative
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Generic
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Type of Manufacturer

7.1 Outsourced
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 In-house
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Synthesis Technology

8.1 Solid Phase Peptide Synthesis
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Liquid Phase Peptide Synthesis
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Hybrid Technology
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Routes of Administration

9.1 Parenteral
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Oral
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Application

10.1 Gastrointestinal Disorders
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Neurological Disorders
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Metabolic Disorders
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
10.4 Cancer
- 10.4.1 Market Trends
- 10.4.2 Market Forecast
10.5 Others
- 10.5.1 Market Trends
- 10.5.2 Market Forecast

11 Market Breakup by Region

11.1 North America
- 11.1.1 United States
  - 11.1.1.1 Market Trends
  - 11.1.1.2 Market Forecast
- 11.1.2 Canada
  - 11.1.2.1 Market Trends
  - 11.1.2.2 Market Forecast
11.2 Asia-Pacific
- 11.2.1 China
  - 11.2.1.1 Market Trends
  - 11.2.1.2 Market Forecast
- 11.2.2 Japan
  - 11.2.2.1 Market Trends
  - 11.2.2.2 Market Forecast
- 11.2.3 India
  - 11.2.3.1 Market Trends
  - 11.2.3.2 Market Forecast
- 11.2.4 South Korea
  - 11.2.4.1 Market Trends
  - 11.2.4.2 Market Forecast
- 11.2.5 Australia
  - 11.2.5.1 Market Trends
  - 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
  - 11.2.6.1 Market Trends
  - 11.2.6.2 Market Forecast
- 11.2.7 Others
  - 11.2.7.1 Market Trends
  - 11.2.7.2 Market Forecast
11.3 Europe
- 11.3.1 Germany
  - 11.3.1.1 Market Trends
  - 11.3.1.2 Market Forecast
- 11.3.2 France
  - 11.3.2.1 Market Trends
  - 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
  - 11.3.3.1 Market Trends
  - 11.3.3.2 Market Forecast
- 11.3.4 Italy
  - 11.3.4.1 Market Trends
  - 11.3.4.2 Market Forecast
- 11.3.5 Spain
  - 11.3.5.1 Market Trends
  - 11.3.5.2 Market Forecast
- 11.3.6 Russia
  - 11.3.6.1 Market Trends
  - 11.3.6.2 Market Forecast
- 11.3.7 Others
  - 11.3.7.1 Market Trends
  - 11.3.7.2 Market Forecast
11.4 Latin America
- 11.4.1 Brazil
  - 11.4.1.1 Market Trends
  - 11.4.1.2 Market Forecast
- 11.4.2 Mexico
  - 11.4.2.1 Market Trends
  - 11.4.2.2 Market Forecast
- 11.4.3 Others
  - 11.4.3.1 Market Trends
  - 11.4.3.2 Market Forecast
11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast

12 SWOT Analysis

12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
- 16.3.1 Amgen Inc.
  - 16.3.1.1 Company Overview
  - 16.3.1.2 Product Portfolio
  - 16.3.1.3 Financials
  - 16.3.1.4 SWOT Analysis
- 16.3.2 Apitope International NV
  - 16.3.2.1 Company Overview
  - 16.3.2.2 Product Portfolio
- 16.3.3 Arch Biopartners Inc.
  - 16.3.3.1 Company Overview
  - 16.3.3.2 Product Portfolio
  - 16.3.3.3 Financials
- 16.3.4 AstraZeneca plc
  - 16.3.4.1 Company Overview
  - 16.3.4.2 Product Portfolio
  - 16.3.4.3 Financials
  - 16.3.4.4 SWOT Analysis
- 16.3.5 Circle Pharma Inc.
  - 16.3.5.1 Company Overview
  - 16.3.5.2 Product Portfolio
- 16.3.6 Corden Pharma GmbH
  - 16.3.6.1 Company Overview
  - 16.3.6.2 Product Portfolio
- 16.3.7 F. Hoffmann-La Roche AG
  - 16.3.7.1 Company Overview
  - 16.3.7.2 Product Portfolio
  - 16.3.7.3 SWOT Analysis
- 16.3.8 Ipsen Group
  - 16.3.8.1 Company Overview
  - 16.3.8.2 Product Portfolio
  - 16.3.8.3 Financials
  - 16.3.8.4 SWOT Analysis
- 16.3.9 Lonza Group AG
  - 16.3.9.1 Company Overview
  - 16.3.9.2 Product Portfolio
  - 16.3.9.3 Financials
  - 16.3.9.4 SWOT Analysis
- 16.3.10 Novo Nordisk A/S
  - 16.3.10.1 Company Overview
  - 16.3.10.2 Product Portfolio
  - 16.3.10.3 Financials
  - 16.3.10.4 SWOT Analysis
- 16.3.11 Pfizer Inc.
  - 16.3.11.1 Company Overview
  - 16.3.11.2 Product Portfolio
  - 16.3.11.3 Financials
  - 16.3.11.4 SWOT Analysis
- 16.3.12 Teva Pharmaceuticals Industries Ltd.
  - 16.3.12.1 Company Overview
  - 16.3.12.2 Product Portfolio
  - 16.3.12.3 Financials
  - 16.3.12.4 SWOT Analysis
- 16.3.13 Zealand Pharma A/S
  - 16.3.13.1 Company Overview
  - 16.3.13.2 Product Portfolio
  - 16.3.13.3 Financials

简介目录图表

List of Figures

Figure 1: Global: Peptide Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Peptide Therapeutics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Peptide Therapeutics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Peptide Therapeutics Market: Breakup by Type (in %), 2022
Figure 5: Global: Peptide Therapeutics Market: Breakup by Type of Manufacturer (in %), 2022
Figure 6: Global: Peptide Therapeutics Market: Breakup by Synthesis Technology (in %), 2022
Figure 7: Global: Peptide Therapeutics Market: Breakup by Routes of Administration (in %), 2022
Figure 8: Global: Peptide Therapeutics Market: Breakup by Application (in %), 2022
Figure 9: Global: Peptide Therapeutics Market: Breakup by Region (in %), 2022
Figure 10: Global: Peptide Therapeutics (Innovative) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Peptide Therapeutics (Innovative) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Peptide Therapeutics (Generic) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Peptide Therapeutics (Generic) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Peptide Therapeutics (Outsourced) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Peptide Therapeutics (Outsourced) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Peptide Therapeutics (In-house) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Peptide Therapeutics (In-house) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Peptide Therapeutics (Solid Phase Peptide Synthesis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Peptide Therapeutics (Solid Phase Peptide Synthesis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Peptide Therapeutics (Liquid Phase Peptide Synthesis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Peptide Therapeutics (Liquid Phase Peptide Synthesis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Peptide Therapeutics (Hybrid Technology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Peptide Therapeutics (Hybrid Technology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Peptide Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Peptide Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Peptide Therapeutics (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Peptide Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Peptide Therapeutics (Other Routes of Administration) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Peptide Therapeutics (Other Routes of Administration) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Peptide Therapeutics (Gastrointestinal Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Peptide Therapeutics (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Peptide Therapeutics (Neurological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Peptide Therapeutics (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Peptide Therapeutics (Metabolic Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Peptide Therapeutics (Metabolic Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Peptide Therapeutics (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Peptide Therapeutics (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Peptide Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Peptide Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: North America: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: North America: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: United States: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: United States: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Canada: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Canada: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Asia-Pacific: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Asia-Pacific: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: China: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: China: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Japan: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Japan: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: India: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: India: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: South Korea: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: South Korea: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Australia: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Australia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Indonesia: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Indonesia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Europe: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Europe: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Germany: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Germany: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: France: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: France: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: United Kingdom: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: United Kingdom: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Italy: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Italy: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Spain: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Spain: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Russia: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Russia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Latin America: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Latin America: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Brazil: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Brazil: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Mexico: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Mexico: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Middle East and Africa: Peptide Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Middle East and Africa: Peptide Therapeutics Market: Breakup by Country (in %), 2022
Figure 88: Middle East and Africa: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Global: Peptide Therapeutics Industry: SWOT Analysis
Figure 90: Global: Peptide Therapeutics Industry: Value Chain Analysis
Figure 91: Global: Peptide Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Peptide Therapeutics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Peptide Therapeutics Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Peptide Therapeutics Market Forecast: Breakup by Type of Manufacturer (in Million US$), 2023-2028
Table 4: Global: Peptide Therapeutics Market Forecast: Breakup by Synthesis Technology (in Million US$), 2023-2028
Table 5: Global: Peptide Therapeutics Market Forecast: Breakup by Routes of Administration (in Million US$), 2023-2028
Table 6: Global: Peptide Therapeutics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 7: Global: Peptide Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 8: Global: Peptide Therapeutics Market: Competitive Structure
Table 9: Global: Peptide Therapeutics Market: Key Players

02-2729-4219

+886-2-2729-4219